Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Sanofi offloads drug programmes to MyoKardia and Acer Therapeutics

pharmaceutical-technologyJanuary 04, 2019

Tag: Sanofi , MyoKardia , Acer Therapeutics

PharmaSources Customer Service